Build
Build your organisation
Meet interim and permanent leaders, board members and advisers who have built and run companies at your stage.
For example: an interim Head of Clinical Operations to set up your first-in-human study.
Bespoke introductions · Pharma & biotech
The people who decide, deliver and know.
Bell Partners introduces pharma and biotech companies to senior decision makers, proven leaders and the experts others turn to. Each introduction is chosen for your situation and made personally.
Illustrative network
Every brief is bespoke. We introduce you to:
Decision makers
Senior people who hold budgets, set strategy and sit on boards.
Leaders
Experienced operators who have built teams and delivered programmes.
Knowledge gurus
Leading clinicians, scientists and specialists whose views carry weight.
What we do
Four ways we can help
We do not use databases or mass matching. Each introduction is chosen for your brief and explained to both sides, so everyone knows why the meeting matters.
Connect
Reach the knowledge gurus
Speak with the senior clinicians and scientists whose views shape trial design, regulatory strategy and investment decisions.
For example: two experienced investigators to review a Phase II protocol before it goes to the regulator.
Upskill
Develop your people
Give your team mentors and practical training from people who have run development programmes themselves.
For example: a former regulatory head to mentor your first-time Head of Regulatory Affairs.
Access
Open new markets
Meet the people who decide on partnering, licensing and investment in the UK, Europe, the US and Asia-Pacific.
For example: a shortlist of European licensing partners for your Phase II asset, with a named contact at each.
How it works
How an introduction works
Every brief is handled personally by senior people who know the industry.
- 1
Tell us what you need
A confidential conversation about your goals, your timing and who you need to meet.
- 2
We choose the right people
We identify the decision makers, leaders and experts who fit your brief, and check they are relevant and available before anyone is approached.
- 3
We introduce and follow up
A personal introduction that explains to both sides why they should meet, followed by a check that the meeting was useful.
The network
Senior people across the industry
People who hold budgets, run functions, sit on boards and have delivered programmes, in every function a growing company needs.
Functions
- Senior management
- Boards & governance
- Research & development
- Clinical & regulatory
- Manufacturing & supply
- Medical affairs
- Commercial & market access
- Business development
- Finance & investment
Regions
- United KingdomLondon, Oxford, Cambridge
- EuropeEU and Switzerland
- United StatesBoston, San Francisco, New Jersey
- Asia-PacificJapan, China, Australia
Our network is confidential. We make an introduction only when both sides agree.
Clients
Who we work with
Companies at every stage, from first funding round to global launch.
Emerging biotechs
Founders building a team and preparing for the clinic.
Scale-ups
Clinical-stage companies that need leaders and new skills quickly.
Pharma
Business development and R&D teams looking for experts and partners.
Investors & boards
Funds and boards that need independent expertise or new executives.
Our principles
Three principles we keep
They shape every brief we accept and every introduction we make.
I
Discretion
Your brief stays confidential. We never share your plans, or the details of anyone in our network, without permission.
II
Quality over volume
We make a few well-chosen introductions, not long lists of names. Each one is made because it is right for you.
III
Personal introductions only
Every introduction is made personally by a partner, who explains to both sides why they should meet.
Contact
Tell us who you need to meet
Tell us a little about your company and what you need. We answer every enquiry personally and in confidence.